Carolina Dybeck Happe
Analyst
Thanks, Larry. Broadly speaking, I'm also pleased with how we're progressing on our priorities. We're becoming more operational. We're deepening our focus on cash flow and we're using lean and automation to improve speed, quality and scale. And you've started to see evidence of this in our margin and cash flow numbers. I'll share some examples with you today. Turning to Slide 4. Larry covered our consolidated results, so let me provide some additional color on our earnings performance. First, we made some notable reporting enhancements. This better aligned with how we operate our businesses and will help us drive improvements. They also further enhance transparency and disclosure quality. Of particular note, we now include restructuring expense expected for significant and higher cost programs in adjusted EPS and in our segment results. This will drive accountability in managing costs and benefit at the businesses. The restructuring recast was an impact of $0.02 in the quarter and $0.05 for the year. Second, we're still managing through significant market volatility. Aviation continues to heavily impact our overall performance, pressuring our top-line and our industrial profit, but we saw progress in our other businesses. This quarter, while overall industrial margin was down 350 basis points, excluding Aviation, margin expanded 340 basis points, reflecting swift actions and strong executions on our cost programs. As planned in 2020, we reduced structural headcount by more than 20,000 or 11%, and that's ex dispositions. Third, looking at continuing to adjusted EPS, much of this difference came from the steps we've taken to improve our financial position and operations. There were a couple of main drivers. This includes our Baker Hughes mark and $124 million of restructuring expense tied to the significant high cost programs. I'd also point out debt tender costs, additional BioPharma-related tax benefit and the remaining $100 million to close out the SEC matter. In all, as our actions took hold, we saw improving results to close this difficult year. Moving to cash. We generated $4.4 billion of industrial free cash flow this quarter, well above our expectations coming into the quarter. This is up $500 million year-over-year, but is also ex-BioPharma, up $900 million. All businesses delivered positive cash flow, largely driven by better working capital management. Cash flow benefited from positive earnings, healthy earnings were strong again this quarter. And together with Power and Renewables were enough to offset Aviation decline. You'll see that there are puts and takes between earnings and other CFOA. As seen in prior quarters, non-cash items such as the Baker Hughes mark-to-market impacted earnings but not cash, and they were offset in other CFOA. Consistent with how we run the business, which strengthens our working capital definition, broadening it to include current contract assets and other current items, while our free cash flow definitions remain unchanged. This quarter, working capital was the biggest driver of our free cash flow, a source of cash at $3.4 billion, this was significantly better sequentially and year-over-year due to seasonal volume and continued operational and financial process improvements. While we're seeing improvements across the board, inventory and payables were the net contributors to cash flow this quarter. Looking at the dynamics. Receivable naturally pressured from the higher seasonal volume in fourth quarter. We also reduced short-term factoring by $1.2 billion this quarter, bringing the total factoring balance down to $6.8 billion. Partially offsetting this was strong collections, resulting in a further decline in past dues and DSOs. Renewables was a standout this year, implementing a standard operating rhythm using lean to reduce its DSOs and its past dues by more than 25%. On inventory, we released $1.6 billion across all businesses through higher deliveries driven by seasonality and more rigorous material management. For example, Healthcare's MR team is implementing a real pull system in production. So far, this has improved on-time delivery by roughly 15 points and increased inventory turns by 0.5 turn. Payables were also a benefit as volume increased this quarter. Progress collections were a net $1 billion inflow. This was driven by cash collected from large orders closed in renewables and strong milestone deliveries, partially offset by Aviation and Power. Contract assets, a net $800 million of inflow, and this was due to Aviation CSA collections, including quarterly flight hours, annual minimum contract requirements and other items. We're still carefully optimizing our investments to drive returns aligned with our long-term objectives. We held CapEx flat sequentially. In fourth quarter, this represents a reduction of more than 50% year-over-year, and for the year, this is down 31%. But importantly, we continue to invest in high-return and strategically important projects. For the year, industrial free cash flow was $600 million. All businesses, except Aviation, improved cash flows and ended the year stronger than they began. Total Power generated positive free cash flow including Gas Power as we made faster progress on our fixed cost reductions and working capital improvements, despite the negative cash flows at Power portfolio. Healthcare delivered an impressive free cash flow of $2.9 billion, while overcoming a $1 billion headwind from the foregone cash flows of BioPharma. This was driven by higher earnings primarily from the pandemic-related demand, cost actions and better working capital. Free cash flow at Renewables was negative $600 million, but a $300 million improvement year-over-year despite the impact of the PTC cycle. The focus on inventory management is paying off, and we had strong progress from orders and milestone execution. Aviation free cash flow turned positive this quarter and was nearly breakeven for the year, enabled by our significant cash actions. Stepping back, our trajectory to sustainable cash flow growth was largely on self-help. I'm confident we're focused on the right areas, operational cash drivers that improve working capital, increasing our frequency of our operating rhythms and more linear cash flow generation throughout the quarters and the year. For example, all leaders have action plans to run their businesses leaner with lower inventory levels. In aggregate, our focus and actions to improve working capital are starting to pay off. Moving to the segment results, which I'll speak to on an organic basis. First, on Aviation. GE and CFM departures were down approximately 48% this quarter versus our January '20 baseline due to the resurgence of COVID-19 cases and further travel restrictions. The commercial aftermarket, which is critical to our recovery, showed some sequential improvement. Orders were down 40% year-on-year, but up more than 50% sequentially. Commercial Services was down more than 50% year-over-year, with commercial engines down 21%. It's important to recall that the fourth quarter of '19 included a $1.9 billion order from the aeroderivative joint venture formation. This was just under half of the total orders decline in dollar terms. Aviation backlog stands at $260 billion, down 5% year-over-year, yet flat sequentially. The largest driver was commercial engines as unit shipments and cancellations outpaced orders. Cancellations were about 400 units, primarily led 1B this quarter, significant. But for context, our ending LEAP backlog still stands at more than 9,600 engines. Revenue decline continued to moderate, down 34% this quarter, while revenue was up nearly 20% sequentially. Commercial engine revenue was down 47% as we shipped 309 fewer engines year-over-year. Commercial Services revenue was down nearly 50%. This was driven by lower spare parts sales and shop visits. Charges for long-term service agreements were approximately $150 million this quarter, roughly 1/3 is COVID-related. While customer demand remained strong in military, revenue was flat, falling short of our expectations. This was due to continued supply chain challenges, slowing shipments. Segment margin, 9.6%. Margin expanded sequentially driven by the cost actions and improved volume in commercial markets. Despite more than $100 million of continued higher costs due to lower production rates. Decremental margins this quarter were 48%, up sequentially. This was due to continued volume pressure and a tough margin comp of 23% from the fourth quarter in '19. So for the year, Aviation margin of 5.6% were supported by significant countermeasures. We realized savings of more than $1 billion of costs and $2 billion of cash actions. This work continues in '21. Moving to Healthcare. The team delivered another strong quarter. The Healthcare Systems market remained dynamic with elevated demand in COVID-19-related equipment, offset by softer demand for non-pandemic products. Regionally, public healthcare markets, such as Europe and China have been stronger than private markets, particularly U.S., India and Latin America. For the second consecutive quarter, global procedure volumes were relatively stable, with some regional variability as care providers postponed elective procedures due to COVID-19 spike. With that backdrop, healthcare orders continued to improve at 1%. In Healthcare Systems, orders grew 1%, Europe was up low double-digits and China up low single-digits. Services saw consistent growth, up low double-digits as we continue to provide critical support to our customers. In PDx demand continues to recover to pre-pandemic level, and orders were down 1%, but up slightly sequentially. Healthcare revenue was up 6%. Healthcare Systems was up 7%, FCF had solid execution, delivering a record number of ventilators. Non-pandemic-related volumes were also positive as we converted imaging backlog and ultrasound orders this quarter. From a regional perspective, we saw strong growth in Europe and China. This year, China revenue was more than $2 billion and up 11% in the quarter alone. U.S. revenue was more than $6.5 billion, up 2% for the year, including the U.S. government ventilator order. PDx revenue slightly down 1%. The segment margin was up 310 basis points this quarter, and 190 basis points for the year. While we continue to invest in new products, the team reduced structural costs, headcount was down roughly 1,200 this quarter, and the business maintained tighter control over discretionary costs. For the year, revenue was up 4%, with Healthcare Systems up 5%, and the margin was 17%. Our team delivered operational improvement and has headroom for more with an eye towards continued margin expansion. Turning to Power. Our team continued to make operational progress, particularly in cash generation. Starting with the market. Despite global electricity demand and gas-based power generation declining this quarter, GE gas turbine utilization, and therefore, our CSA billings were resilient, increasing mid-single digits, driven by our technology and commercial positioning in higher growth gas favored regions. As anticipated, we saw significant orders improvement. Gas Power equipment order more than tripled with HA wins in Asia and securing 45 to 50 heavy-duty gas turbine shipments in 2021. Service orders grew 7%, with double-digit growth in transactional and low single-digit growth in CSA, while upgrade declined moderated from earlier in 2020, down single digits. For the year, service orders were down 3%. Power portfolio orders were down 27%, largely driven by steam equipment. As we exit new build coal, this trend of limited steam equipment activity has continued. And as we execute backlog and rightsize the business, we expect this to flow through the financials. We ended with slightly higher backlog as growth in Gas Power more than offset declines in Power portfolio. Gas Power backlog of $66 billion grew roughly $700 million sequentially, driven by strong equipment and transactional services book-to-bill. Revenue was down slightly this quarter. In Gas Power revenue was down 3%, largely driven by services down 10%. We saw lower discretionary spend on upgrades and narrower scope of outages. For the year, we executed about 90% of our pre-COVID outage plan. Offsetting this was equipment revenue up double digits. We shipped 28 gas turbines this quarter, up 7 units year-over-year, for a total of 51 heavy-duty shipments in 2020, and we commissioned 4 gigawatts of power to the grid, including six HA units. In Power portfolio, revenue was up 5% primarily driven by steam equipment project execution. Our Power portfolio team performed about 95% of their pre-COVID outage plans. Segment margin of 6% was up 40 basis points, a double-digit reduction in Gas Power fixed costs was partially offset by negative revenue mix between equipment and services and some one-time non-cash charges, including for specific customer credit event. In Power portfolio, as Larry mentioned, all 3 businesses generated profit. Power conversion was a particular standout. Better execution led to margin expansion of 10 points year-over-year. For the year, Power revenues were down 5%, but has held margins at 1.5%. We offset pressure from lower services volume and one-time non-cash charges such as an underperforming joint venture for global aeroderivative packaging by reducing headcount by roughly 3,300 and decreasing Power fixed costs. Turning to Renewables. Our progress continues. This year, onshore wind delivered record volumes despite the pandemic. Offshore wind received full certification for both its 12-and 13-megawatt Haliade-X. In grid and hydro, our turnaround, showed improved results. Starting with the market. Onshore wind growth was sustained by international demand. Offshore wind continued to be supported by solid secular growth trends. And we've built a robust Haliade-X pipeline with total commitments of 5.7 gigawatts. Orders were up 32% year-over-year, representing the first quarter of growth since the third quarter in '19. This was driven by onshore wind with large equipment orders in North America and offshore wind with its first Haliade-X order of 95 units from the Dogger Bank wind farm in the UK. This double-digit order growth brings our backlog to a record high of $30 billion, and importantly, at better margins. We remain focused on underwriting discipline and better project selectivity. Revenue was down 7% driven by onshore wind, specifically, new units and repower upgrades were down 27% as our deliveries were more heavily weighted in the prior quarter due to the PTC dynamics. This was partially offset by growth in offshore wind and hybrids. Segment margin was slightly negative this quarter, though up 290 basis points year-over-year, was driven by cost productivity better pricing in onshore in North America and improved project execution. At grid, profit, while negative, improved significantly driven by our restructuring actions and better project execution. For Renewables, revenue was up for the year, and while the segment margin improved, it was still negative. Moving to GE Capital on Slide 7. We ended the year with $103 billion of assets, excluding liquidity. Continuing operations generated an adjusted net loss of $24 million this quarter. This was down year-over-year, primarily driven by lower gains at GECAS and EFS and higher taxes, partially offsetting lower EFS impairments and positive marks on the insurance investment portfolio. At GECAS, our team continued to work customer-by-customer through restructuring and, in some cases, repossessions. At year-end, the outstanding deferred balance was approximately $400 million. This was down slightly sequentially, both as a function of limited new deferrals as well as collections. Importantly, we've collected around 84% of what we've invoiced to date, and out of fleet of more than 900 aircraft, we ended the year with 27 aircraft on ground. This quarter, GECAS generated a profit of $120 million. That's down $94 million year-over-year driven primarily by the disposition of the PK Air in 2019 and market conditions. For the year, GECAS generated earnings of $50 million, excluding the second quarter goodwill impairment. Equipment lease impairments in the year totaled $542 million and $45 million in the quarter. Going forward, we continue to monitor credit risk as further credit deterioration could result in additional airline failures over and above those that we have considered in our reviews. Turning to insurance. The business generated net income of $112 million this quarter. This was largely driven by increases in the unrealized gains in the invested securities portfolio and in mark-to-market adjustments and realized gains. As it relates to the pandemic and adjusting for what we believe is timing related, in our LTC block, we continue to see reductions in new claims and higher policy terminations. In our runoff life business, we saw -- we still saw higher claims due to higher mortality. In our structured settlement block, we also saw higher mortality resulting in lower claims. Insurance will complete its annual statutory cash flow test in the first quarter of '21. As expected, GE provided a capital contribution to GE Capital of $2 billion, in line with the required annual insurance statutory funding for 2020. As we said in the third quarter, we expect an additional contribution from GE to GE Capital in '21 to meet its existing insurance statutory funding requirements of approximately $2 billion. In light of the uncertain environment, further 2021 contributions depend on GE Capital's performance, including GECAS' operations and the insurance CFT results. Shifting to corporate. Our focus on decentralization continues. We're driving more accountability to the segments and continue to resize the core in favor of the business units. This quarter, adjusted corporate costs were $443 million, down 23% year-over-year. Functional costs and operations improved as we saw further reduced headcount, which was down 13% for the year. GE Digital saw significant traction on profit and cash flow as the business improved operations and optimized its cost structure. Moving to Slide 8. We continue to improve our financial position despite the uncertain external environment. We ended the year with about $37 billion of total cash, more than $23 billion at GE and $13 billion at GE Capital. We also maintained $20 billion of credit lines. And through a series of actions this year, we reduced near-term liquidity needs through 2024 by $10.5 billion. We also continued to enhance our cash management operations, targeting more linear cash flow, lower factoring and less restricted cash. As a result, we reduced intra-quarter borrowings by $3.6 billion in 2020 or approximately 75% less year-over-year. Expanding on cash flow linearity. One focus area for our businesses has been improving the end-to-end cycle of order fulfillment, billing and collections. In our Healthcare System equipment business, for example, standard work is helping us level load the number of deliveries from the third month in the quarter to earlier in the quarter, smoothing out deliveries and collections. This is also reducing inventory and improving factory productivity. These types of operational improvements have reduced our industrial cash needs to below $13 billion on a go-forward basis. And this creates greater capacity to delever the company. However, we'll continue to hold elevated cash levels through this period of uncertainty. Turning to debt reduction. We made strong progress in 2020, reducing external debt by $16 billion, and our industrial net debt ended at $32 billion, down $16 billion in '20 and down $23 billion from '19. We also continue to derisk and actively manage our pension. In 2020, we decreased our pension deficit by $2.3 billion. The combination of strong asset returns at 17.6% and recent actions, such as the $2.5 billion pension prefunding, more than offset the impact of low interest rates. Based on our current assumptions, we won't need to make contributions through 2023 to the GE pension plan. In terms of leverage levels, industrial ended with a 5.9 times debt-to-EBITDA ratio due to lower EBITDA, reflecting pandemic-related pressure. We remain committed to achieving our industrial leverage target of 2.5 times net debt-to-EBITDA over time. At GE Capital, we ended 2020 with a debt-to-equity ratio of 3.4%. And we expect to remain below our 4 times debt-to-equity target. In closing, our team has made meaningful progress this year. I'm encouraged by results we're seeing from the many, many changes underway. We'll continue to build on this momentum in 2021. Now Larry, back to you.